The use of anti-human immunodeficiency virus (HIV) drugs after occupational exposure to HIV is a proven method of preventing some HIV infection and there is record that these drugs are being used in treatment of post exposure infection to HIV. This then raises the issues of the impact of such treatment on the staffs. The objective of the study was to asses the level of knowledge attitudes and practices of (PEP) against HIV among surgical staffs. 190 questionnaires were sent to staffs in the department of surgery but One twenty nine (68%) was returned. Questionnaires contained items related to awareness of occupational exposure to HIV and 0.77% had experience of its use in the department and 100% noted that there was no specific policy in re...
Nigeria ranks top among the countries with the highest burden of Human Immune-deficiency Virus (HIV)...
The use of anti‐human immunodeficiency virus (HIV) drugs after occupational exposure to HIV is a pro...
The first instance of human immunodeficiency virus reported in 1984 and HIV/AIDS declared as public ...
The use of anti-human immunodeficiency virus (HIV) drugs after occupational exposure to HIV is a pro...
The use of anti-human immunodeficiency virus (HIV) drugs after occupational exposure to HIV is a pro...
Infection with HIV is an occupational risk to health care workers, especially doctors, during treatm...
Infection with HIV is an occupational risk to health care workers, especially doctors, during treatm...
Percutaneous transmission of HIV is a significant occupational risk among health workers. Post-expos...
Background: Post exposure chemoprophylaxis can prevent human immunodeficiency virus (HIV) infection ...
Background : Access to HIV care and treatment has improved over the past several years, but safety s...
Introduction: timely PEP after needle stick exposure to high risk body fluids can reduce the rate of...
Introduction: timely PEP after needle stick exposure to high risk body fluids can reduce the rate of...
Background: The mainstay of prevention of occupationally-acquired HIV infection is compliance with u...
Background. Postexposure chemoprophylaxis can prevent human immunodeficiency virus (HIV) infection i...
Background:According to World Health Organization (WHO) estimation, about 2.5% of all human immunode...
Nigeria ranks top among the countries with the highest burden of Human Immune-deficiency Virus (HIV)...
The use of anti‐human immunodeficiency virus (HIV) drugs after occupational exposure to HIV is a pro...
The first instance of human immunodeficiency virus reported in 1984 and HIV/AIDS declared as public ...
The use of anti-human immunodeficiency virus (HIV) drugs after occupational exposure to HIV is a pro...
The use of anti-human immunodeficiency virus (HIV) drugs after occupational exposure to HIV is a pro...
Infection with HIV is an occupational risk to health care workers, especially doctors, during treatm...
Infection with HIV is an occupational risk to health care workers, especially doctors, during treatm...
Percutaneous transmission of HIV is a significant occupational risk among health workers. Post-expos...
Background: Post exposure chemoprophylaxis can prevent human immunodeficiency virus (HIV) infection ...
Background : Access to HIV care and treatment has improved over the past several years, but safety s...
Introduction: timely PEP after needle stick exposure to high risk body fluids can reduce the rate of...
Introduction: timely PEP after needle stick exposure to high risk body fluids can reduce the rate of...
Background: The mainstay of prevention of occupationally-acquired HIV infection is compliance with u...
Background. Postexposure chemoprophylaxis can prevent human immunodeficiency virus (HIV) infection i...
Background:According to World Health Organization (WHO) estimation, about 2.5% of all human immunode...
Nigeria ranks top among the countries with the highest burden of Human Immune-deficiency Virus (HIV)...
The use of anti‐human immunodeficiency virus (HIV) drugs after occupational exposure to HIV is a pro...
The first instance of human immunodeficiency virus reported in 1984 and HIV/AIDS declared as public ...